{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:23Z","timestamp":1791182003643,"version":"4.1.0"},"reference-count":18,"publisher":"American Diabetes Association","issue":"8","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Hemipancreatectomy (HPx) for the purpose of organ donation has been associated with a 25% risk of developing abnormal glucose tolerance or diabetes in the year after surgery. Since 1997, the University of Minnesota has imposed criteria to prevent potential donors with clinical features associated with an increased diabetes risk from undergoing HPx. We recently assessed glucose tolerance in hemipancreatectomized donors selected since the adoption of the new criteria to determine whether the risk of developing abnormal glucose tolerance was reduced below the 25% rate previously demonstrated.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Individuals who underwent HPx for the purpose of pancreas donation between 1997 and 2003 were contacted and interviewed about their health status. Those not taking diabetes medications were invited to undergo an assessment of their glucose tolerance.<\/jats:p>\n               <jats:p>RESULTS\u2014Successful contact was made with 15 of 21 donors who underwent HPx during this period. Two donors reported use of oral diabetic medications and were not studied further. Of the remaining 13, 2 had impaired fasting glucose (fasting blood glucose 100\u2013125 mg\/dl), 1 had impaired glucose tolerance (2-h postglucose load blood glucose 140\u2013199 mg\/dl), and 3 displayed both. One donor met the diagnostic criteria for diabetes. Six donors had normal glucose values.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Despite the use of stringent criteria to exclude those at risk for developing abnormalities in glucose metabolism, 43% of healthy humans who underwent HPx between 1997 and 2003 have impaired fasting glucose, impaired glucose tolerance, or diabetes on follow-up. The current preoperative criteria are insufficient to predict those who will develop abnormal glucose metabolism after HPx.<\/jats:p>","DOI":"10.2337\/dc07-2453","type":"journal-article","created":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T00:49:14Z","timestamp":1212799754000},"page":"1639-1643","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":56,"title":["Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism"],"prefix":"10.2337","volume":"31","author":[{"given":"Anjali F.","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer W.G.","family":"Gruessner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Seaquist","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031219253097500_R1","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med\u2008329: 977\u2013986, 1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031219253097500_R2","doi-asserted-by":"crossref","unstructured":"Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes\u200854:3592\u20133601, 2005","DOI":"10.2337\/diabetes.54.12.3592"},{"key":"2022031219253097500_R3","unstructured":"International Pancreas Transplant Registry: 2004 Annual Report. Minneapolis, University of Minnesota, 2005, Fig. 1"},{"key":"2022031219253097500_R4","doi-asserted-by":"crossref","unstructured":"Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg\u2008233:463\u2013501, 2001","DOI":"10.1097\/00000658-200104000-00003"},{"key":"2022031219253097500_R5","doi-asserted-by":"crossref","unstructured":"Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP: Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med\u2008322:898\u2013903, 1990","DOI":"10.1056\/NEJM199003293221305"},{"key":"2022031219253097500_R6","doi-asserted-by":"crossref","unstructured":"Seaquist ER, Robertson RP: Effects of hemipancreatectomy on pancreatic \u03b1 and \u03b2 cell function in healthy human donors. J Clin Invest\u200889:1761\u20131766, 1992","DOI":"10.1172\/JCI115779"},{"key":"2022031219253097500_R7","doi-asserted-by":"crossref","unstructured":"Gruessner RW, Kendall DM, Drangstveit MB, Gruessner AC, Sutherland DE: Simultaneous pancreas-kidney transplantation from live donors. Ann Surg\u2008226:471\u2013482, 1997","DOI":"10.1097\/00000658-199710000-00008"},{"key":"2022031219253097500_R8","doi-asserted-by":"crossref","unstructured":"Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes\u200852:1128\u20131136, 2003","DOI":"10.2337\/diabetes.52.5.1128"},{"key":"2022031219253097500_R9","doi-asserted-by":"crossref","unstructured":"American Diabetes Association: Diagnosis and classification of diabetes. Diabetes\u200856:S42\u2013S47, 2007","DOI":"10.2337\/dc07-S042"},{"key":"2022031219253097500_R10","doi-asserted-by":"crossref","unstructured":"Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS, Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS: Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA\u2008103:14074\u201314079, 2006","DOI":"10.1073\/pnas.0606349103"},{"key":"2022031219253097500_R11","doi-asserted-by":"crossref","unstructured":"Gruessner RWG: Living donor pancreas transplantation. In Transplantation of the Pancreas. Gruessner RWG, Sutherland DER, Finch ME, Eds. New York, Springer Verlag, 2004, p.425\u2013427","DOI":"10.1007\/978-1-4757-4371-5"},{"key":"2022031219253097500_R12","unstructured":"Bolinder J, Gunnarsson R, Tyden G, Brattstrom C, Ostman J, Groth CG: Metabolic effects of living related pancreatic graft donation. Transplant Proc\u200820: 475\u2013478, 1988"},{"key":"2022031219253097500_R13","doi-asserted-by":"crossref","unstructured":"Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D Jr, Robertson RP: Hyperproinsulinemia is associated with increased \u03b2 cell demand after hemipancreatectomy in humans. J Clin Invest\u200897:455\u2013460, 1996","DOI":"10.1172\/JCI118435"},{"key":"2022031219253097500_R14","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes\u200852:102\u2013110, 2003","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2022031219253097500_R15","doi-asserted-by":"crossref","unstructured":"Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC: Relationship between \u03b2-cell mass and fasting blood glucose concentration in humans. Diabetes Care\u200829:717\u2013718, 2006","DOI":"10.2337\/diacare.29.03.06.dc05-1538"},{"key":"2022031219253097500_R16","doi-asserted-by":"crossref","unstructured":"Matveyenko AV, Veldhuis JD, Butler PC: Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes\u200855:2347\u20132356, 2006","DOI":"10.2337\/db06-0345"},{"key":"2022031219253097500_R17","doi-asserted-by":"crossref","unstructured":"Seaquist ER, Pyzdrowski K, Moran A, Teuscher AU, Robertson RP: Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia\u200837:1036\u20131043, 1994","DOI":"10.1007\/BF00400467"},{"key":"2022031219253097500_R18","doi-asserted-by":"crossref","unstructured":"Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER: Relationship between diabetes and obesity 9\u201318 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation\u200873:736\u2013741, 2002","DOI":"10.1097\/00007890-200203150-00013"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/8\/1639\/599513\/zdc00808001639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/8\/1639\/599513\/zdc00808001639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T20:57:52Z","timestamp":1647118672000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/8\/1639\/28501\/Risk-of-Glucose-Intolerance-and-Diabetes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-2453","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]}}}